Brain Hemorrhage Epidemiology Forecast 2025-2034

Brain hemorrhage or bleeding in the brain is a type of stroke that can be life-threatening, with the 5-year survival rate estimated to be around 26.7%. The incidence of subdural hemorrhage is reported to be between 5% and 25% in patients with a serious head injury, whereas subarachnoid hemorrhage is estimated to have an incidence of nearly 2 to 25 per 100,000 person-years for individuals who are above the age of 35. The brain hemorrhage epidemiology forecast suggests that the incidence and burden of brain hemorrhage are expected to increase globally, driven primarily by aging populations, rising rates of hypertension, and lifestyle-related risk factors.

Brain Hemorrhage Epidemiology Forecast Report Coverage

The “Brain Hemorrhage Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of brain hemorrhage. It projects the future incidence and prevalence rates of brain hemorrhage cases across various populations. The study covers age, gender, and type as major determinants of the brain hemorrhage population. The report highlights patterns in the prevalence of brain hemorrhage over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of brain hemorrhage in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Brain Hemorrhage Understanding: Disease Overview

A brain hemorrhage or brain bleed causes blood to pool between the brain and skull, preventing oxygen from reaching the brain. There are various types of brain bleeds: epidural bleeds, subdural bleeds, and subarachnoid bleeds occur within the skull but outside of brain tissue, whereas intracerebral hemorrhage and intraventricular hemorrhage are the types of brain bleeds that occur inside the brain tissue.

The first symptom of a brain hemorrhage is a sudden, painful headache. Studies show there is an increasing need for preventive strategies, early risk factor screening, and improved access to acute care and rehabilitation services to manage the long-term impact of brain hemorrhages.

Brain Hemorrhage Epidemiology Perspective

The brain hemorrhage epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for the brain hemorrhage epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for brain hemorrhage and their trends. The brain hemorrhage detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Epidural hemorrhage, a type of brain hemorrhage, is present in around 5% to 15% of fatal head injury cases. Approximately 3.1 million individuals worldwide need surgical intervention as a result of traumatic epidural hemorrhage each year, as per a 2022 systematic review and meta-analysis.
• Spontaneous intracerebral hemorrhage (ICH), one of the most serious types of brain hemorrhage, has a mortality rate of about 40%-50% that typically occurs in the first days, with only 12% to 39% of the patient population remaining functionally independent within 6 months.
• The incidence of subarachnoid hemorrhage is estimated to be about 2 to 25 per 100,000 person-years for people over 35 years of age and is found to be more frequent in women than men (female-to-male ratio is 1.15:1).
• Brain hemorrhage is a type of stroke, with over 795,000 individuals affected by a stroke every year in the United States, according to the Cleveland Clinic.

Age-Based Brain Hemorrhage Epidemiology Insights

A 2022 study published in the American Heart Association journal Stroke found that intracerebral hemorrhage (ICH), a type of brain hemorrhage, increased by 11% among United States adults from 2004 to 2018. The rise of this brain hemorrhage was more pronounced in adults under 65, particularly in the 18-44 and 45-64 age groups, compared to those aged 75 and older. This highlights a growing risk of ICH in younger populations, highlighting the need for early prevention and risk factor management.

Gender-Based Brain Hemorrhage Epidemiology Insights

According to a 2024 study using a population-based registry tracking first-time cases of intracerebral hemorrhage (ICH) from 2011 to 2020, the annual incidence of this brain hemorrhage subtype was lower in women (20.2 per 100,000) than in men (30.2 per 100,000). Over the study period, incidence rates remained stable in both sexes. However, women had a higher 1-year mortality rate after ICH (48.5% vs. 40.1%), suggesting possible sex-based differences in outcomes.

Country-wise Brain Hemorrhage Epidemiology Segment

The brain hemorrhage epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of brain hemorrhage varies between countries owing to differences in the incidence of risk factors (such as hypertension, alcohol consumption, smoking, and obesity), healthcare infrastructure (availability of neurosurgical intervention and advanced imaging technologies), lifestyle patterns, and socioeconomic conditions. As per a study published in the Lancet Regional Health - Europe, deaths from brain hemorrhages caused by strokes are projected to rise by 40% in the United Kingdom .

Brain Hemorrhage: Treatment Overview

Depending on the severity and location of the bleed, treatment options for brain hemorrhage can include medications or surgery. Prompt treatment is reported to improve the chances of recovery and can also limit damage to the brain. Surgical interventions may include craniectomy, craniotomy, or decompression, based on the bleed’s location, size, and underlying cause. Pain relievers, anti-anxiety medications, steroid medications, or antiseizure medications are some of the brain hemorrhage therapeutics that are prescribed to manage the symptoms.

In cases of intracerebral hemorrhage (ICH), medical management includes controlling elevated blood pressure, reversing the effects of anticoagulant medications if the patient is on blood thinners, and using medications like mannitol or hypertonic saline to reduce brain swelling. Seizures, if present in brain hemorrhage patients, are managed with antiepileptic drugs, and supportive care is provided to stabilize other physiological parameters.

Key Questions Answered

• What are the key findings of brain hemorrhage epidemiology in the 8 major markets?
• What will be the total number of patients with brain hemorrhage across the 8 major markets during the forecast period?
• What was the country-wise brain hemorrhage epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of brain hemorrhage patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of brain hemorrhage during the forecast period of 2025-2034?
• What are the currently available treatments in the brain hemorrhage market?
• What are the disease risks, signs, symptoms, and unmet needs of brain hemorrhage?

Scope of the Brain Hemorrhage Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of brain hemorrhage based on several factors.
• Brain Hemorrhage Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The brain hemorrhage report helps to identify the patient population and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

This product will be delivered within 3-5 business days.